Comparing surgical and non-surgical treatments for two-part proximal humerus fractures
Official title: Conservative Versus Operative Treatment of Two - Part Proximal Humerus Fractures
Run by University Hospital, Akershus · NCT04106674 · Data updated 2026-11-12
This study is testing whether surgery or non-surgical treatment works better for older adults with certain shoulder fractures.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years to 85 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | University Hospital, Akershus Academic / other |
| Locations | 1 site (Lørenskog, Oslo) |
| Status | Recruiting |
| Started | October 1, 2020 |
| Main results expected | October 1, 2024 |
| Study ends | October 31, 2034 |
| Registry record updated | October 25, 2022 |
| Trial ID | NCT04106674 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients aged 60 to 85 with displaced two-part proximal humeral fractures requiring treatment.
✕Probably not a fit
Patients with fractures older than three weeks or those who refuse to participate will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of surgical versus conservative management for displaced two-part proximal humerus fractures in patients aged 60 to 85. Participants will be randomly assigned to receive either open reduction and internal fixation (ORIF) or non-operative treatment. The study will assess functional outcomes using the Quick DASH score and other evaluations at multiple follow-up points over a year. The trial is designed as a single-blinded randomized controlled trial conducted at Akershus University Hospital.
Why it matters
Potential benefit: If successful, this study could provide insights into the most effective treatment approach for elderly patients with proximal humerus fractures, potentially improving recovery outcomes.
How similar studies have gone: Other studies have explored surgical versus non-surgical treatments for similar fractures, but this specific comparison in the elderly population is less common, making it a valuable investigation.
Who can join: the full rules
Show full inclusion / exclusion criteria
-The study-design is a single center single blinded randomized controlled trial (RCT) with 3 arms. Patients admitted to Akershus University Hospital with a displaced 2-part proximal humeral fracture of OTA/ AO group 11A2 or 11A3 in need of surgical treatment will be randomly allocated to two groups; conservative/ non-operative treatment or open reduction and internal fixation (ORIF). The patients allocated to ORIF will be randomly allocated to either the Philos plate (Synthes) or the Multiloc nail (Synthes). Inclusion criteria 1. Patients \> 60 years and \<85 years 2. More than 50% displacement between head or shaft or 50⁰ angulation of the head against the shaft in Y-projection or more than 45 ˚ valgus or more than 30˚ varus of the Head Shaft Angle (HSA). 3. Patient with tuberculum majus or minor fractures which displaced \<5mm can be included as long as points 1 and 2 above are fulfilled. Exclusion Criteria: * Refusal to participate in the study * Fracture more than 3 weeks old * No contact btw head and shaft * Ipsilateral damage that will influence the recovery and scoring systems * Incapability to protect osteosynthesis, i.e. use of crutches because of injury to lower extremity. This is up to the treating surgeon to decide * Pathological fracture or previous fracture of the same proximal humerus * Multitrauma or "multifractured patient" * Neurovascular injury * Open fracture * Noncompliance, dementia and/ or institutionalized * Congenital anomaly * Ongoing infectious process around the incision site for osteosynthesis * Systemic disease that may influence healing processes or scoring systems (in example Rheumatoid arthritis/Multiple sclerosis/ poorly controlled DM) * Fracture dislocation * Substance abuse * Inability to read and understand Norwegian * Patients not residing in our catchment area * Patients with a diameter of the humerus to small for nailing, will be allocated to the Philos-group. * Any medical condition that excludes surgical treatment, including patients with ASA 3 or 4 that are considered too ill to go through surgery.
Where it's running
-
Akershus University Hospital
Lørenskog, Oslo, Norway Recruiting
Study contacts
- Study coordinator: Annette Konstanse Bordewich Wikerøy, MD
- Email: awikeroy@hotmail.com
- Phone: 004799717481
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tipmed Shoulder Prosthesis PMCF: safety and outcomes after shoulder replacement
This PMCF study tests the safety and function of the Tipmed shoulder prosthesis in adults undergoing reverse shoulder or hemiarthroplasty in real-world practice.
-
Evaluating the Anatomical Shoulder 2.0 Fracture System for shoulder surgeries
This study is testing how well the Anatomical Shoulder 2.0 Fracture System works for shoulder surgeries by looking at patient outcomes and any complications over time.
-
Structured psychological coaching to support recovery after surgically treated shoulder (proximal humerus) fracture
This trial tests whether adding structured psychological coaching to usual care helps adults with high neuroticism recover better after surgical repair of a proximal humerus (shoulder) fracture.
-
EASY Algorithm: Bedside ultrasound to screen children aged 5 to 15 for elbow fractures
This project will test whether a quick bedside ultrasound can reliably show or rule out elbow fractures in children aged 5 to 15 after an injury.
-
Ultrasound to find elbow fractures in children
This trial tests whether using bedside ultrasound instead of X-rays helps children who come to the ER with elbow pain.
-
Pain control options after elbow surgery in children
This study is testing two different ways to manage pain after elbow surgery in kids to see which one works better and uses fewer strong medications.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.